NewsBenzingaTakeda Pharmaceutical Co Raises FY2026 GAAP EPS Guidance from JPY 104 to JPY 131 Takeda Pharmaceutical Co Raises FY2026 GAAP EPS Guidance from JPY 104 to JPY 131 Benzinga 2026.10.29 07:56 (GMT+0) Open on Benzinga Other news BBVA Q3 Adj. EPS $0.61 Misses $0.62 Estimate, Sales $12.560B Miss $12.580B Estimate MSFT Stock Eyes Best Day In Over 3 Months After Earnings Beat — Gene Munster Says 'Software Is Alive And Well, At Least For Now' ING Groep Q3 EPS $0.75 Misses $0.79 Estimate, Sales $7.167B Beat $7.000B Estimate Takeda Pharmaceutical Co Raises FY2026 Core EPS Guidance from JPY 472 to JPY 482; Raises FY2026 Revenue Guidance from JPY 4,640B to JPY 4,700B Takeda Pharmaceutical Q2 Adj. EPS $0.48 Beats $0.31 Estimate, Sales $7.457B Beat $7.190B Estimate Anthropic's 'Deviously Self-Serving' Voting Structure ‘Would Put Kim Jong Un to Shame,’ says Aswath Damodaran
MSFT Stock Eyes Best Day In Over 3 Months After Earnings Beat — Gene Munster Says 'Software Is Alive And Well, At Least For Now'
Takeda Pharmaceutical Co Raises FY2026 Core EPS Guidance from JPY 472 to JPY 482; Raises FY2026 Revenue Guidance from JPY 4,640B to JPY 4,700B
Anthropic's 'Deviously Self-Serving' Voting Structure ‘Would Put Kim Jong Un to Shame,’ says Aswath Damodaran
